ClearPoint Neuro, Inc. cotiza a 9.85 USD y tiene una capitalización bursátil de $300M. En los últimos 12 meses ha facturado $42M con un margen de flujo de caja libre del -66.1%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.38 | $-0.32 | $-0.27 |
| Estimado | $-0.31 | $-0.29 | $-0.27 | $-0.20 |
| Sorpresa | — | -31.0% | -18.5% | -35.0% |
| Métrica | CLPT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 61.4% | 57.0% | +4.3% |
| Operating Margin | -65.4% | -38.6% | -26.7% |
| Net Margin | -69.1% | -33.6% | -35.5% |
| FCF Margin | -66.1% | -13.9% | -52.3% |
| ROE | -91.2% | -40.4% | -50.8% |
| ROA | -26.1% | -32.0% | +5.9% |
| Current Ratio | 5.91 | 2.84 | +3.07 |
| Debt / Equity | 1.75 | 0.28 | +1.47 |